Thalys Medical Technology Group Inc.

Shanghai Stock Exchange 603716.SS

Thalys Medical Technology Group Inc. EPS (Diluted) for the year ending December 31, 2023: USD -0.12

Thalys Medical Technology Group Inc. EPS (Diluted) is USD -0.12 for the year ending December 31, 2023, a 20.30% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

Thalys Medical Technology Group Inc. EPS (Diluted) for the year ending December 31, 2022 was USD -0.14, a -360.38% change year over year.
Thalys Medical Technology Group Inc. EPS (Diluted) for the year ending December 31, 2021 was USD -0.03, a -148.92% change year over year.
Thalys Medical Technology Group Inc. EPS (Diluted) for the year ending December 31, 2020 was USD 0.06, a -19.99% change year over year.
Thalys Medical Technology Group Inc. EPS (Diluted) for the year ending December 31, 2019 was USD 0.08, a 12.87% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

Shanghai Stock Exchange: 603716.SS

Thalys Medical Technology Group Inc.

CEO	Mr. Zheng Wang
IPO Date	Oct. 31, 2016
Location	China
Headquarters	1310 Jinshan Avenue
Employees	1,406
Sector	Healthcare
Industries Biotechnology 3D Printing Defense & Military Dental Care Hardware & Electronics Medical Instruments Pharmaceuticals Telehealth

Description

Thalys Medical Technology Group Inc. engages in the medical intensive business and operation services in China. The company was formerly known as Thalys Medical Technology Inc. and changed its name to Thalys Medical Technology Group Inc. in September 2020. Thalys Medical Technology Group Inc. was founded in 2004 and is headquartered in Wuhan, China.

Key trends

Past 5 years